Investigation on the molecular mechanisms of antigen presentation and recognition.
抗原呈递和识别的分子机制研究。
基本信息
- 批准号:14370115
- 负责人:
- 金额:$ 8.9万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Presentation of antigenic peptides by antigen presenting cells and consequent stimulation of CD4^+ T cells is crucial in the regulation of immune response. In this research project, we studied on the recognition of antigenic peptide by T cell receptor (TCR) and signal transduction pathway in CD4^+ T cells stimulated with altered peptide ligands (APL). In addition, we established a method for ES cell-based genetic engineering of dendritic cells (DC). The following results were obtained.1)We developed an experimental system to dentify diverse T-cell epitopes from T-cell epitope-expression library, using an epitope presenting vector based on CLIP-substituted invariant chain. Using the libraries in which randomized amino acid residues were narrowed down into three successive ones, we characterized the degeneracy in the epitopes of the GAD65-reactive Th-cell clones derived from IDDM patients, and identified several microbe-derived antigens to which the Th-cell clones cross-reacted.2)We foun … More d that a human CD4^+ T cell clone showed full proliferation in response to over-expressed partially agonistic peptide/HLA-DR4 complex. However, a protein tyrosine kinase ZAP-70, which is believed to be essential for TCR-mediated T cell activation, was not tyrosine-phosphorylated and activated. Instead, we found that other kinases B-Raf and PKCm were activated in the T cells, suggesting the presence of new signaling pathways leading to full T cell proliferation that is independent of ZAP-70 activation.3)We established a method to generate mouse ES cell-derived DC (ES-DC). Genetic modification of ES-DC can be done by transfection of ES cells and subsequent differentiation to DC. OVA antigen-specific cytotoxic T lymphocytes were efficiently primed in vivo by injecting mice with ES-DCs introduced with an OVA-expression vector. Double-transfectant ES-DC expressing a chemokine along with OVA provided potent protection from OVA-expressing tumor cells. In addition, we demonstrated prevention of experimental autoimmune encephalomyelitis by treatment with genetically modified ES-DC. Less
通过抗原呈递细胞和随之而来的CD4^+ T细胞的刺激对抗原性宠物表示至关重要。在该研究项目中,我们研究了T细胞受体(TCR)对抗原肽的识别,以及用改变的肽配体(APL)刺激的CD4^+ T细胞中的信号转移途径。此外,我们还建立了一种基于ES细胞的树突状细胞基因工程(DC)的方法。 1)我们使用基于基于夹子取代的不变链的表位呈现向量的表位来从T细胞表位表达式文库中牙齿牙齿的T细胞表位牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿牙齿的,从而获得以下结果。1)1)。使用将随机氨基酸存活的文库缩小为三个成功的图书馆,我们表征了来自IDDM患者的GAD65反应性TH细胞克隆的脱位,并确定了几个微生物衍生的抗原,并在th-ded Clone crossected forsect.2)中表明了th-clone form.2),这表明了人类的反应。部分激动剂肽/HLA-DR4复合物。然而,据信对于TCR介导的T细胞激活至关重要的蛋白酪氨酸激酶ZAP-70并非被酪氨酸磷酸化和激活。取而代之的是,我们发现其他激酶B-RAF和PKCM我们建立了一种生成小鼠ES细胞衍生的DC(ES-DC)的方法。 ES细胞的遗传修饰可以通过转染ES细胞并随后分化为DC来完成。 OVA抗原特异性细胞毒性T淋巴细胞通过在体内有效启动,通过将小鼠注入带有OVA表达载体的ES-DC。表达趋化因子以及OVA的双转移ES-DC为表达OVA表达的肿瘤细胞提供了有效的保护。此外,我们通过一般修饰的ES-DC治疗可以预防实验性自身免疫性脑脊髓炎。较少的
项目成果
期刊论文数量(135)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Irie, A. et al.: "Unique T cell proliferation associated with PKCm activation and impaired Zap-70 phosphorylation in recognition of overexpressed HLA/partially agonistic peptide complexes"Eur.J.Immunol.. 33. 1497-1507 (2003)
Irie, A. 等人:“识别过表达的 HLA/部分激动肽复合物时与 PKCm 激活和 Zap-70 磷酸化受损相关的独特 T 细胞增殖”Eur.J.Immunol.. 33. 1497-1507 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Senju, S., Hirata, S., Matsuyoshi, H., Masuda, M., Uemura, Y., Araki, K., Yamamura, K-I., Nishimura, Y.: "Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells."Blood. 101. 3501-3508 (2003)
Senju, S.、Hirata, S.、Matsuyoshi, H.、Masuda, M.、Uemura, Y.、Araki, K.、Yamamura, K-I.、Nishimura, Y.:“衍生自树突状细胞的生成和遗传修饰
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakatsura, T., Yoshitake, Y., Senju, S., Monji, M., Komori, H., Motomura, Y., Hosaka, S., Beppu, T., Ishiko, T., Kamohara, H., Ashihara, H., Katagiri, T., Furukawa, Y., Fujiyama, S., Ogawa, M., Nakamura, Y., Nishimura, Y.: "Glypican-3, overexpressed speci
Nakatsura, T.、Yoshitake, Y.、Senju, S.、Monji, M.、Komori, H.、Motomura, Y.、Hosaka, S.、Beppu, T.、Ishiko, T.、Kamohara, H.、
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Soejima, H.: "The preference to a Th1-type response in patients with coronary spastic angina"Circulation. (in press).
Soejima, H.:“冠状动脉痉挛性心绞痛患者对 Th1 型反应的偏好”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
千住 覚, 西村泰治: "樹状細胞による抗原のプロセシングと提示"医学のあゆみ. 200・6. 467-471 (2002)
Satoru Senju、Yasuharu Nishimura:“树突状细胞的抗原处理和呈递”医学史 200・6(2002 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIMURA Yasuharu其他文献
NISHIMURA Yasuharu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIMURA Yasuharu', 18)}}的其他基金
Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
开发新的癌症免疫疗法,旨在激活抗肿瘤杀伤细胞和辅助 T 细胞
- 批准号:
24300334 - 财政年份:2012
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
利用人PS细胞衍生的树突状细胞和理想的癌症相关抗原开发细胞癌症免疫疗法
- 批准号:
23650609 - 财政年份:2011
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Identification of tumor-specific antigens recognized by human T cells
人类 T 细胞识别的肿瘤特异性抗原的鉴定
- 批准号:
12213111 - 财政年份:2000
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
THE DIVESITY IN ANTIGEN RECOGNITION AND RESPONSE OF ANTIGEN-SPECIFIC HUMAN CD4^+ T-CELL CLONES
抗原特异性人类 CD4^ T 细胞克隆的抗原识别和反应的多样性
- 批准号:
11557027 - 财政年份:1999
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of TCR/HLA/ peptide interaction and investigation of etiology of autoimmune diseases
TCR/HLA/肽相互作用分析及自身免疫性疾病病因学研究
- 批准号:
11694294 - 财政年份:1999
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ANALYSIS OF AUTOANTIGENIC PEPTIDE-HLA CLASS II COMPLEXES ASSOCIATED WITH AUTOIMMUNE DISEASES
与自身免疫性疾病相关的自身抗原肽-HLA II 类复合物的分析
- 批准号:
09470097 - 财政年份:1997
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An approach to generate a library of CHO cells expressing diverse HLA class II plus peptide complexes for identification of TCR-ligands by using CLIP-substituted invariant chains
一种生成表达多种 HLA II 类加肽复合物的 CHO 细胞文库的方法,用于通过使用 CLIP 取代的不变链鉴定 TCR 配体
- 批准号:
08557027 - 财政年份:1996
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS
使用 HLA II 类结合肽基序识别和预测 T 细胞表位
- 批准号:
06454222 - 财政年份:1994
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
HLA多态性对抗原肽与HLA结合及T细胞受体识别HLA复合肽的影响
- 批准号:
03452276 - 财政年份:1991
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Production of monoclonal antibody specific to HLA by utilizing HLA transgenic mice.
利用 HLA 转基因小鼠生产 HLA 特异性单克隆抗体。
- 批准号:
01870026 - 财政年份:1989
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
相似国自然基金
KIF17介导肿瘤细胞MHC-II胞膜定位促进乳腺癌抗原提呈及免疫应答的机制研究
- 批准号:82372781
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
耐受性DC通过Wnt5a信号通路调控MHC-II+CD8+Treg诱导免疫耐受的机制研究
- 批准号:82370665
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于MHC-II/CD72/Sema4D轴调控神经元-T细胞通讯探讨知母黄柏药对防治糖尿病脑病神经免疫调节机制
- 批准号:82304909
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向TRIM24通过促进三阴性乳腺癌MHC-I表达增强免疫治疗疗效的研究
- 批准号:82372783
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
New mechanism of autoimmune diseases mediated by misfolded protein/MHC class II complex
错误折叠蛋白/MHC II类复合物介导自身免疫性疾病的新机制
- 批准号:
15H02545 - 财政年份:2015
- 资助金额:
$ 8.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ROLE OF MHC CLASS I IN THE GENERATION OF AUTOIMMUNE DISEASES
I 类 MHC 在自身免疫性疾病产生中的作用
- 批准号:
2463796 - 财政年份:
- 资助金额:
$ 8.9万 - 项目类别:
ROLE OF MHC CLASS I IN THE GENERATION OF AUTOIMMUNE DISEASES
I 类 MHC 在自身免疫性疾病产生中的作用
- 批准号:
3774432 - 财政年份:
- 资助金额:
$ 8.9万 - 项目类别:
ROLE OF MHC CLASS I IN THE GENERATION OF AUTOIMMUNE DISEASES
I 类 MHC 在自身免疫性疾病产生中的作用
- 批准号:
3752139 - 财政年份:
- 资助金额:
$ 8.9万 - 项目类别:
ROLE OF MHC CLASS I IN THE GENERATION OF AUTOIMMUNE DISEASES
I 类 MHC 在自身免疫性疾病产生中的作用
- 批准号:
6289269 - 财政年份:
- 资助金额:
$ 8.9万 - 项目类别: